IDEAYA Biosciences Inc.
IDYA | NASDAQ
$38.86
+$0.45 (+1.17%)
At close: Sep 21, 2026, 4:00 PM ET
$38.86
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $3.65B
Enterprise Value $2.9B
Beta -0.09
Average Volume 996.45K
Shares Outstanding (Diluted) 92.06M
Shares Change YoY 4.06%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US45166A1025
Price Performance
Price Change 1M -1.7%
Price Change 3M 11.3%
Price Change 6M 23.8%
Price Change YTD 14.8%
Price Change 1Y 49.9%
Price Change 3Y 40.6%
Price Change 5Y 53.1%
1M CAGR (ann.) 6.0%
1Y CAGR (ann.) 57.2%
5Y CAGR (ann.) 7.6%
All-Time CAGR 18.3%
Valuation
PE Ratio -20.03
Forward PE N/A
PEG Ratio -1.02
Forward PEG 1.96
PS Ratio 15.78
Forward PS 32.00
PB Ratio 3.08
P/FCF Ratio -19.45
P/Adj. FCF Ratio -14.23
P/OCF Ratio -19.14
EV/Sales 12.37
EV/EBIT -16.54
EV/EBITDA -17.09
EV/FCF -15.24
Earnings Yield -5.0%
FCF Yield -5.1%
Adj. FCF Yield -7.0%
Financial Health
Net Cash $828.96M
Total Debt $29.31M
Cash & Short-Term Investments $828.96M
Total Assets $1.31B
Current Ratio 10.45
Quick Ratio 10.45
Debt / Equity Ratio 0.02
Debt / EBITDA -0.17
Debt / FCF -0.15
OCF / Debt -6.38
Interest Coverage 0.00
Altman Z-Score 19.22
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -13.3%
Operating Profit Margin -92.7%
EBITDA Margin -90.8%
Net Profit Margin -74.8%
FCF Margin -81.2%
Adj. FCF Margin -110.9%
SBC / Revenue 29.8%
SBC Impact (per share) -36.7%
Returns
Return on Assets -13.4%
Return on Equity -16.5%
Return on Invested Capital -17.7%
Return on Capital Employed -17.7%
Return on Tangible Assets -13.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 73.1%
Revenue CAGR 5Y 45.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 4.7%
EPS CAGR 5Y -12.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y -13.4%
FCF CAGR 5Y -26.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 26
EPS Growth Next 3Y 7.1%
Revenue Growth Next 3Y 34.3%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$1.18
EPS Growth Est (next Q) -188.6%
Revenue Est (next Q) $6.84M
Revenue Growth Est (next Q) -96.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $57
Price Target Upside 46.7%
Cash Flow
Operating Cash Flow $-186.83M
Free Cash Flow $-190.01M
Adj. Free Cash Flow $-259.75M
FCF Per Share -$2.06
OCF Per Share -$2.03
OCF/S Ratio -79.8%
Income Statement
Revenue $234.13M
Gross Profit $63.39M
Operating Income $-216.95M
EBITDA $-169.39M
Net Income $-175.02M
EPS (Diluted) -$1.94
Revenue / Employee $1.61M
Profit / Employee $-1.21M
Employees 145
Add to Watchlist
Select watchlists to add or remove IDYA